Provention Bio says FDA extends review period for co’s teplizumab application to Nov. 17 by adminPosted onJune 30, 2022 Read More
Accolade GAAP EPS of -$4.92 misses by $4.18, revenue of $85.5M beats by $3.53M by adminPosted onJune 30, 2022 Read More
With lower close, S&P 500 suffers worst first half in more than 50 years; Nasdaq, Dow also fall by adminPosted onJune 30, 2022 Read More
Celsius Network scouts out ‘strategic transactions’, other options amid solvency concerns by adminPosted onJune 30, 2022 Read More
Pinterest among worst big performers as investors process new CEO by adminPosted onJune 30, 2022 Read More
Acumen Pharmaceuticals initiated at buy at H.C. Wainwright on Alzheimer’s candidate by adminPosted onJune 30, 2022 Read More
Fortis cut to Sell at UBS on ‘significant’ regulatory headwinds by adminPosted onJune 30, 2022 Read More
